Anne Heirman

PDA Impact in Advanced Larynx Cancer | 137 5 CRT (T1) N=12 Usual Care CRT (T1) N=10 Intervention P-value RT (T1) N=16 Usual Care RT (T1) N=24 Intervention P-value T2 N=26 Usual care T2 N=30 Intervention P-value 45% (9) 20-75% 65% (13) 45-90% 0.002 43% (8.5) 15-85% 75% (15) 5-95% 0.002 55% (11) 5-85% 62.5% (12.5) 15-95% 0.136 38% (3) 0-87.5% 56.3% (4.5) 0-87.5% 0.346 25% (2) 0-75% 56.3% (4.5) 0-100% 0.002 37.5% (3) 0-87.5% 62.5% (5) 0-100% 0.067 80% (4) 20-100% 100% (5) 80-100% 0.007 80% (4) 0-100% 100% (5) 20-100% 0.002 80% (4) 20-100% 100% (5) 0-100% 0.002 43% (3) 0-100% 85.7% (6) 43-100% 0.180 38% (2.5) 0-87.5% 71.4% (5) 0-100% 0.044 50% (3.5) 0-100% 57% (4) 0-100% 0.914 Significant p-values are highlighted in bold.T1, directly after counseling; T2, six months after treatment; TL = Total Laryngectomy, RT = Radiation Therapy, CRT = Chemo Radiation Therapy. *This group also includes patients that received postoperative radiation therapy after TL

RkJQdWJsaXNoZXIy MTk4NDMw